<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Lymphokine activated killer (LAK) cells generated in the presence of <z:chebi fb="2" ids="27899">cisplatin</z:chebi>/FK-565 along with interleukin-2 (IL-2) showed enhanced binding to <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells as compared with LAK cells generated in the presence of IL-2 alone </plain></SENT>
<SENT sid="1" pm="."><plain>The LAK cells showed a reorientation of cellular organelles in the presence of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells </plain></SENT>
<SENT sid="2" pm="."><plain>LAK-<z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> conjugate pairs showed vesicle-like structures in the extracellular pockets </plain></SENT>
<SENT sid="3" pm="."><plain>The number of vesicles in the extracellular pockets was found to be increased in the case of LAK cells generated in the presence of <z:chebi fb="2" ids="27899">cisplatin</z:chebi>/FK-565 along with IL-2 </plain></SENT>
<SENT sid="4" pm="."><plain>The closer interaction between the LAK cell-target cell and the large number of vesicles in the extracellular space of conjugate pairs may explain the increased lysis of target cells by LAK cells generated in the presence of <z:chebi fb="2" ids="27899">cisplatin</z:chebi>/FK-565 along with IL-2 as compared with IL-2 alone </plain></SENT>
</text></document>